Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Summary: Hutchinson–Gilford progeria syndrome (HGPS), a fatal premature aging disease, is caused by a single‐nucleotide mutation in the LMNA gene. Previous reports have focused on nuclear phenotypes in HGPS cells, yet the potential contribution of the mitochondria, a key player in normal aging, remains unclear. Using high‐resolution microscopy analysis, we demonstrated a significantly increased fraction of swollen and fragmented mitochondria and a marked reduction in mitochondrial mobility in HGPS fibroblast cells. Notably, the expression of PGC‐1α, a central regulator of mitochondrial biogenesis, was inhibited by progerin. To rescue mitochondrial defects, we treated HGPS cells with a mitochondrial‐targeting antioxidant methylene blue (MB). Our analysis indicated that MB treatment not only alleviated the mitochondrial defects but also rescued the hallmark nuclear abnormalities in HGPS cells. Additional analysis suggested that MB treatment released progerin from the nuclear membrane, rescued perinuclear heterochromatin loss and corrected misregulated gene expression in HGPS cells. Together, these results demonstrate a role of mitochondrial dysfunction in developing the premature aging phenotypes in HGPS cells and suggest MB as a promising therapeutic approach for HGPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“The majority of ROS is generated inside of mitochondria, and dysfunctional mitochondria will directly and indirectly elevate ROS production (Lin & Beal, 2006; Chen et al., 2007).”
BackgroundOxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055 · cited 2×
“Mitochondria are complex organelles that are believed to play a significant role in biological aging (Shigenaga et al., 1994; Bratic & Larsson, 2013).”
BackgroundMitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Goldman, R. D., Shumaker, D. K., Erdos, M. R., Eriksson, M., Goldman, A. E., Gordon, L. B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402943101 · Cited by 1,103 · cited 2×
“…high levels of nuclear abnormalities including nuclear blebbing, altered chromatin organization, transcriptional changes, and aberrant mitosis (Goldman et al., 2002, 2004; Columbaro et al., 2005; Liu et al., 2005; Shumaker et al., 2006; Cao et al., 2007; Dechat et al., 2007, 2008; McCord et…”
BackgroundThe role of mitochondria in aging
Bratic, A., & Larsson, N.-G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64125 · Cited by 1,087
Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging
Shumaker, D. K., Dechat, T., Kohlmaier, A., Adam, S. A., Bozovsky, M. R., Erdos, M. R., Eriksson, M., Goldman, A. E., Khuon, S., Collins, F. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602569103 · Cited by 791 · cited 2×
“The abnormal presence of progerin disrupts the integrity of the nucleoskeleton, causing high levels of nuclear abnormalities including nuclear blebbing, altered chromatin organization, transcriptional changes, and aberrant mitosis (Goldman et al., 2002, 2004; Columbaro et al., 2005; Liu et al., 2005; Shumaker et al.,…”
BackgroundGenomic instability in laminopathy-based premature aging
Liu, B., Wang, J., Chan, K. M., Tjia, W. M., Deng, W., Guan, X., Huang, J.-D., Li, K. M., Chau, P. Y., Chen, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1266 · Cited by 650
Harrison, D. E., Strong, R., Allison, D. B., Ames, B. N., Astle, C. M., Atamna, H., Fernandez, E., Flurkey, K., Javors, M. A., Nadon, N. L., et al. (2014) · Aging Cell · doi:10.1111/acel.12170 · Cited by 445 · cited 2×
“MB is an effective agent to delay cellular senescence at nanomolar concentration and prevent age-related decline in cognitive function and grip strength (Atamna et al., 2008; Harrison et al., 2014).”
BackgroundCao, K., Graziotto, J. J., Blair, C. D., Mazzulli, J. R., Erdos, M. R., Krainc, D., & Collins, F. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002346 · Cited by 350
Self-citationMethylene Blue Delays Cellular Senescence and Enhances Key Mitochondrial Biochemical Pathways
Atamna, H., Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H., & Ames, B. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9610com · Cited by 272
Cited by
Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases
Kubben, N., & Misteli, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.68 · Cited by 320
The role of the light source in antimicrobial photodynamic therapy
Piksa, M., Lian, C., Samuel, I. C., Pawlik, K. J., Samuel, I. D. W., & Matczyszyn, K. (2023) · Chemical Society Reviews · doi:10.1039/d0cs01051k · Cited by 320
Wilcock, G. K., Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170560 · Cited by 219
Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells
Carrero, D., Soria-Valles, C., & López-Otín, C. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024711 · Cited by 153
“…HGPS treatments studied in cell-based and animal models include the administration of sodium salicylate, which inhibits the I κ B kinase (IKK) complex (Osorio et al., 2012), pyrophosphate (Villa-Bellosta et al., 2013), methylene blue (Xiong et al., 2016) and Icmt inhibitors (Ibrahim et al., 2013).”
Anti-Aging Potentials of Methylene Blue for Human Skin Longevity
Xiong, Z.-M., O’Donovan, M., Sun, L., Choi, J. Y., Ren, M., & Cao, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-02419-3 · Cited by 112
Self-citationMetabolic Dysfunction in Hutchinson–Gilford Progeria Syndrome
Kreienkamp, R., & Gonzalo, S. (2020) · Cells · doi:10.3390/cells9020395 · Cited by 45
“In addition, progerin expression causes an increase in swollen and fragmented mitochondria, and decreased mitochondrial movement, possibly related to reduced availability of cellular ATP for proper microtubule-mediated transport [57].”
BackgroundOxidative Status Predicts Quality in Human Mesenchymal Stem Cells
Bertolo, A., Capossela, S., Fränkl, G., Baur, M., Pötzel, T., & Stoyanov, J. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0452-7 · Cited by 36
“The beneficial role of MB was demonstrated in a mouse model of Hutchinson-Gilford progeria—a premature aging syndrome—where MB rescued damaged mitochondria and prolonged the in vitro lifespan of cell cultures to levels similar to that of the wild-type control [25].”
BackgroundLin, H., Mensch, J., Haschke, M., Jäger, K., Köttgen, B., Dernedde, J., Orsó, E., & Walter, M. (2022) · Cells · doi:10.3390/cells11182784 · Cited by 11
Metadata
- Authors
- Xiong, Z., Choi, J. Y., Wang, K., Zhang, H., Tariq, Z., Wu, D., Ko, E., LaDana, C., Sesaki, H., & Cao, K.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2015-12-14
- Volume
- 15
- Issue
- 2
- Pages
- 279-290
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- OpenAlex
- W2198293015
- Cited by
- 118
- References
- 11
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.